Disease/Infection News

RSS

Singaporean study looks at WhatsApp behaviours during COVID-19 pandemic

A team of scientists from Singapore has recently studied the pattern of coronavirus disease 2019 (COVID-19) related WhatsApp usage in a group of people.

30 Sep 2020

NIH awards $5 million grant to reduce COVID-19-related health disparities

To help reduce COVID-19-related health disparities in vulnerable populations in Texas, a multi-institutional team of researchers led by The University of Texas Health Science Center at Houston will identify disease hotspots and testing deserts in three racially diverse areas, and then develop and evaluate intervention strategies to increase COVID-19 testing.

30 Sep 2020

New trial to evaluate anti-TNF drug as a treatment for COVID-19 patients begins

Researchers at the University of Oxford are starting a new study to explore the effectiveness of the anti-tumour necrosis factor (anti-TNF) drug adalimumab as a treatment for patients with COVID-19 in the community, especially care homes.

30 Sep 2020

Discovery of high affinity binders for SARS-CoV-2 spike protein

An exciting, 'tour-de-force' paper by researchers from the Massachusetts Institute of Technology describes de novo discovery of high-affinity peptide binders for SARS-CoV-2 spike glycoprotein, which opens the door for the development of rapid viral identification or conjugates for virus-directed delivery of therapeutics.

30 Sep 2020

Study shows delirium as a possible warning sign of COVID-19 in frail, older adults

A new analysis of data from researchers at King's College London using information from the COVID Symptom Study app and patients admitted to St Thomas' Hospital in London, has shown that delirium - a state of acute confusion associated with a higher risk of serious illness and death - is a key symptom of COVID-19 in frail, older people.

30 Sep 2020

SARS-CoV-2 D614G variant enhances infectivity, replication and transmission

Researchers in the United States and Japan have conducted a study showing a common mutation in the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) - the agent that causes coronavirus disease 2019 (COVD-19) - enhances the infectivity, replication, and early transmission of the virus.

30 Sep 2020

Newly developed fusion protein could improve COVID-19 research

Researchers at the Paul Scherrer Institute in Switzerland have developed a high-quality recombinant virus protein that could be applied in the development of vaccines against the 2019 novel coronavirus (2019-nCoV) and in the detection of novel viruses or antibodies.

30 Sep 2020

What we know about the airborne spread of the coronavirus

The federal government did a quick pivot on the threat of the coronavirus spreading through the air, changing a key piece of guidance over the weekend.

30 Sep 2020

Danish vs. Swedish data shows social interaction major risk factor for SARS-CoV-2 infection

A new study published on the preprint server medRxiv* in September 2020 compares the prevalence of antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Danish and Swedish healthcare workers, to conclude that “social interaction is one of the biggest risk factors for getting infected with SARS-CoV-2.”

30 Sep 2020

Study shows how human cells fight viral infections with the emergence of SARS-CoV-2

Science's pursuits of unraveling how human cells fight viral infections kicked into high gear in 2020 with the devastating emergence of the SARS-CoV-2 virus.

30 Sep 2020

New research supports evidence of airborne transmission of COVID-19 in enclosed spaces

New research from the University of Georgia supports growing evidence for airborne transmission of COVID-19 in enclosed spaces.

30 Sep 2020

Political leaders and media should acknowledge uncertainties in epidemiological models, shows study

Scientists, policymakers and the media should acknowledge inherent uncertainties in epidemiological models projecting the spread of COVID-19 and avoid "catastrophizing" worst-case scenarios, according to new research from Cornell University.

30 Sep 2020

A TLR2 agonist reduces SARS-CoV-2 in upper respiratory tract of ferret model

In a recent bioRxiv* preprint paper, Professor Miles W. Carroll et al. study an agonist for reducing the SARS-CoV-2's viral load. They show that prophylactic intra-nasal administration of TLR2/6 (toll-like receptor) agonist, INNA-051, reduces viral RNA in the nose and throat, in a ferret model.

30 Sep 2020

COVID-19 has created a perfect storm for people with heart disease

The COVID-19 pandemic is creating a perfect storm for heart health, the World Heart Federation warns on World Heart Day.

30 Sep 2020

COVID-19 has created a perfect storm for people with heart disease

The COVID-19 pandemic is creating a perfect storm for heart health, the World Heart Federation warns on World Heart Day.

30 Sep 2020

Researchers develop research model to understand the impact of coronavirus on lungs

Scientists at Boston University's National Emerging Infectious Diseases Laboratories (NEIDL) and the Center for Regenerative Medicine (CReM) joined forces to develop the most relevant research model possible for understanding how the coronavirus virus impacts the lungs, by engineering living, "breathing" human lung cells from stem cells for the task.

30 Sep 2020

Abacus Diagnostica's new multiplex assay provides reliable influenza, COVID-19 diagnosis in 75 minutes

Abacus Diagnostica is a small Finnish company developing and manufacturing assays and devices for rapid molecular diagnostics. Since the beginning of COVID-19 outbreak the company has worked decisively on the development of SARS-CoV-2 diagnostics.

30 Sep 2020

Novel nasal treatment could protect people from COVID-19

A novel nasal treatment developed to boost the natural human immune system to fight common colds and flu, has proved remarkably successful in reducing COVID-19 viral replication test results, released today, reveal.

30 Sep 2020

Survey: 37% of UK consumers say temperature checks are critical to COVID-19 safety

37 per cent of UK consumers have said that since the outbreak of COVID-19, they would be more likely to visit pubs, restaurants and hotels which have temperature checking in place for customer safety.

30 Sep 2020

Sleep apnea increases risk of severe COVID 19

Coronavirus disease (COVID-19) is a respiratory disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. A subset of COVID-19 patients face a severe form of the disease with hospitalization, respiratory failure, or death. Severe COVID-19 is primarily characterized by respiratory distress, and the common risk factors are older age, obesity, cardiovascular disease, diabetes, and poor lung function.

29 Sep 2020

Disease/Infection News

Singaporean study looks at WhatsApp behaviours during COVID-19 pandemic

NIH awards $5 million grant to reduce COVID-19-related health disparities

New trial to evaluate anti-TNF drug as a treatment for COVID-19 patients begins

Discovery of high affinity binders for SARS-CoV-2 spike protein

Study shows delirium as a possible warning sign of COVID-19 in frail, older adults

SARS-CoV-2 D614G variant enhances infectivity, replication and transmission

Newly developed fusion protein could improve COVID-19 research

What we know about the airborne spread of the coronavirus

Danish vs. Swedish data shows social interaction major risk factor for SARS-CoV-2 infection

Study shows how human cells fight viral infections with the emergence of SARS-CoV-2

New research supports evidence of airborne transmission of COVID-19 in enclosed spaces

Political leaders and media should acknowledge uncertainties in epidemiological models, shows study

A TLR2 agonist reduces SARS-CoV-2 in upper respiratory tract of ferret model

COVID-19 has created a perfect storm for people with heart disease

COVID-19 has created a perfect storm for people with heart disease

Researchers develop research model to understand the impact of coronavirus on lungs

Abacus Diagnostica's new multiplex assay provides reliable influenza, COVID-19 diagnosis in 75 minutes

Novel nasal treatment could protect people from COVID-19

Survey: 37% of UK consumers say temperature checks are critical to COVID-19 safety

Sleep apnea increases risk of severe COVID 19

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Latest News